DE69802498D1 - Idebenon enthaltendes kombinationspräparat zur alzheimer behandlung - Google Patents

Idebenon enthaltendes kombinationspräparat zur alzheimer behandlung

Info

Publication number
DE69802498D1
DE69802498D1 DE69802498T DE69802498T DE69802498D1 DE 69802498 D1 DE69802498 D1 DE 69802498D1 DE 69802498 T DE69802498 T DE 69802498T DE 69802498 T DE69802498 T DE 69802498T DE 69802498 D1 DE69802498 D1 DE 69802498D1
Authority
DE
Germany
Prior art keywords
idebenon
product containing
combination product
alzheimer treatment
alzheimer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69802498T
Other languages
English (en)
Other versions
DE69802498T2 (de
Inventor
Masaomi Miyamoto
Hiroyuki Ohta
Giichi Goto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of DE69802498D1 publication Critical patent/DE69802498D1/de
Publication of DE69802498T2 publication Critical patent/DE69802498T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69802498T 1997-01-17 1998-01-14 Idebenon enthaltendes kombinationspräparat zur alzheimer behandlung Expired - Fee Related DE69802498T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP614797 1997-01-17
PCT/JP1998/000109 WO1998031356A1 (en) 1997-01-17 1998-01-14 Idebenone containing combination agent for treating alzheimer's disease

Publications (2)

Publication Number Publication Date
DE69802498D1 true DE69802498D1 (de) 2001-12-20
DE69802498T2 DE69802498T2 (de) 2002-07-04

Family

ID=11630417

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69802498T Expired - Fee Related DE69802498T2 (de) 1997-01-17 1998-01-14 Idebenon enthaltendes kombinationspräparat zur alzheimer behandlung

Country Status (4)

Country Link
EP (1) EP0952826B1 (de)
AU (1) AU5495398A (de)
DE (1) DE69802498T2 (de)
WO (1) WO1998031356A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9800526D0 (en) 1998-01-12 1998-03-11 Ciba Geigy Ag Organic compounds
US6316023B1 (en) * 1998-01-12 2001-11-13 Novartis Ag TTS containing an antioxidant
JP4422342B2 (ja) * 1998-11-27 2010-02-24 ザノヒェミア・ファルマツォイティカ・アー・ゲー せん妄の治療へのコリン作動性中枢神経系エフェクターの使用
JP2004292316A (ja) * 2000-12-25 2004-10-21 Nikken Chem Co Ltd アルツハイマー型痴呆の日常生活動作能力改善剤
EP2133340B1 (de) 2002-12-20 2013-01-16 Glaxo Group Limited Neuartige Benzazepin-Derivate
US12274703B2 (en) 2017-12-21 2025-04-15 Gliapharm Sa Compositions and methods of treatment for neurological disorders comprising a dementia
US12310967B2 (en) 2017-12-21 2025-05-27 Gliapharm Sa Compositions and methods of treatment for neurological disorders comprising motor neuron diseases
WO2020132378A2 (en) 2018-12-22 2020-06-25 Gliapharm Sa Compositions and methods of treatment for neurological disorders comprising depression

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4550113A (en) * 1982-08-19 1985-10-29 Nauchno-Issledovatelsky Institut Po Biologicheskikm Ispytaniyam Khimicheskikh Soedineny 9-Amino-2,3,5,6,7,8-hexahydro-1H-cyclopenta(b)quinoline monohydrate hydrochloride as stimulant of neuro-muscular transmission of smooth muscles
FR2558162B1 (fr) * 1984-01-17 1986-04-25 Adir Nouveaux derives de la xanthine, leurs procedes de preparation et les compositions pharmaceutiques les renfermant
IL74497A (en) * 1985-03-05 1990-02-09 Proterra Ag Pharmaceutical compositions containing phenyl carbamate derivatives and certain phenyl carbamate derivatives
JP2503571B2 (ja) * 1988-02-26 1996-06-05 武田薬品工業株式会社 脳循環代謝改善剤
TW197435B (de) * 1990-11-22 1993-01-01 Takeda Pharm Industry Co Ltd
ATE184788T1 (de) * 1993-06-18 1999-10-15 Takeda Chemical Industries Ltd Idebenone-haltige zusammensetzungen zur behandlung von m. alzheimer

Also Published As

Publication number Publication date
AU5495398A (en) 1998-08-07
WO1998031356A1 (en) 1998-07-23
DE69802498T2 (de) 2002-07-04
EP0952826B1 (de) 2001-11-14
EP0952826A1 (de) 1999-11-03

Similar Documents

Publication Publication Date Title
DE59712045D1 (de) Vorrichtung zur behandlung des herzens
ATE200863T1 (de) Indolinonverbindungen zur behandlung von krankheiten
DE69806579D1 (de) Anlage zur behandlung von nahrungsmitteln
DE69936890D1 (de) Vorrichtung zur Behandlung von Ischämie
DE69814070D1 (de) Sterilisationsverfahren
DE69939058D1 (de) Vorrichtung zur behandlung von peripheren gefässerkrankungen
ATE279407T1 (de) Fsh mimetika zur behandlung von infertilität
DE69833699D1 (de) Gefässverschliessende Vorrichtung zur Behandlung von Aneurismen
DE60019556D1 (de) 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit
DE69732152D1 (de) Vorrichtung zur Behandlung von Kopfschmerzen
DE69737402D1 (de) Vorrichtung zur Behandlung von neurodegenerativen Störungen
DE60019555D1 (de) 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
EP0709090A3 (de) Zusammensetzungen zur Behandlung von resistenten Tumoren
ATE235236T1 (de) Unsubstituierte polydiallylaminen zur behandlung von hypercholesterolemia
DE60136477D1 (de) Retinoide zur behandlung von emphysem
DE69427774D1 (de) Kontinuierliches verfahren zur behandlung von nahrungsmitteln
DE59804331D1 (de) Desinfektionsverfahren
ATE279386T1 (de) Retinoide zur behandlung von emphysem
DE69737067D1 (de) Vakzine zur behandlung von mycosen
DE69807466D1 (de) Triptolid-derivate nützlich zur behandlung von autoimmunkrankheiten
DE69905214D1 (de) Mittel zur Behandlung der Osteoporose
DE69802498D1 (de) Idebenon enthaltendes kombinationspräparat zur alzheimer behandlung
DE69913380D1 (de) Zusammensetzung zur behandlung von periodontalen erkrankungen
DE60021252D1 (de) Antikonvulsiva zur behandlung von autismus
DE69834937D1 (de) Antibiotika zur behandlung von magengeschwuren

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee